Contact Us
Drug Search Results
More Filters [+]

Veltuzumab

Alternative Names: veltuzumab, ha20
Latest Update: 2024-05-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: CD20 Antagonist

Novel Mechanism: No

Modality: Antibody

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Gilead Sciences
Company Location: FOSTER CITY CA 94404
Company CEO: Daniel P. O’Day
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Veltuzumab

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Lymphoma, Non-Hodgkin|Chronic Lymphoid Leukemia|Purpura, Thrombocytopenic, Idiopathic|Prolymphocytic Leukemia|Arthritis, Rheumatoid|Lymphoma, B-Cell|Lymphoma|Waldenstrom Macroglobulinemia|Prolymphocytic B-Cell Leukemia|Lymphocytic Chronic B-Cell Leukemia|Follicular Lymphoma|Diffuse Large B-Cell Lymphoma|Precursor Cell Lymphoblastic Leukemia-Lymphoma|Leukemia, Plasma Cell|Acute Lymphoid Leukemia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
IM-T-hA20/90Y-hLL2-01

P2

Withdrawn

Lymphoma, Non-Hodgkin|Diffuse Large B-Cell Lymphoma

2016-12-01

42%
OSU-09024

P2

Completed

Lymphoma, B-Cell|Lymphoma, Non-Hodgkin

2015-04-01

Monoclonal Antibodies In Recurrent B cell ALL (MARALL)

P2

Terminated

Lymphoma

2014-10-03

MARALL

P2

Unknown status

Lymphoma, B-Cell|Precursor Cell Lymphoblastic Leukemia-Lymphoma|Acute Lymphoid Leukemia

2014-08-01

Recent News Events

Date

Type

Title

05/01/2024

PubMed

 Implementing Machine Learning approaches for accelerated prediction of bone strain in acetabulum of a hip joint.

03/07/2024

PubMed

 The Complexity of Being A20: From Biological Functions to Genetic Associations.

03/01/2024

PubMed

 Sex Differences in Prehospital Identification of Large Vessel Occlusion in Patients With Suspected Stroke.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions